CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

CorMedix Inc.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Parabilis Medicines, Inc. (PBLS) and Cormedix (CRMD)...

Analysts Are Bullish on Top Healthcare Stocks: Parabilis Medicines, Inc. (PBLS), Cormedix (CRMD)

Cormedix ( ($CRMD) ) has shared an announcement. On July 24, 2026, the U.S. District Court for the District of New Jersey granted preliminary appro...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CRMD	$7.54	0.00%	6.07M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CRMD	$7.54	0%	6.07M
3
4
5
6

CRMD

Get CorMedix Inc. Data in Excel

Get CorMedix Inc. Data in Excel